JPRN-UMIN000030007招募中未知
Phase1/2 study of Nabpaclitaxel,Gemcitabine,S1 combination therapy for unresectable pancreatic cancer - GENeS1S
Kobe University Hospital Department of Hematology and Oncology0 个研究点目标入组 24 人开始时间: 2017年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Interstitial pneumonitis or pulmonary fibrosis 2.uncontorolled diabetes, liver failure, angina pectoris,myocardial infarction within 3 months after the onset 3.severe infection 4.pregnant woman,lactation,possibility or intention of pregnancy 5.serious drug allergy 6.psychiatric symptoms or mental illness 7.Moderate or severe ascites, pleural effusion 8.uncontrolled watery diarrhea 9.unsuitable for safely carrying out this trial 10.double cancer affected performance status
研究者
相似试验
进行中（未招募）
1 期
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
不适用
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer.pancreatic cancerJPRN-UMIN000017751Department of Surgery, Keio University School of Medicine30
已完成
不适用
Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000030551Mie university15
已完成
不适用
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerJPRN-UMIN000026525Chiba Cancer Center30